Haddad, G., Dylewski, J., Evans, R., Lewis, L
not approved for human, clinical, or veterinary use Available Dosages 10 mg, 20 mg (18 mg) 5-Amino-1MQ is a synthetic research compound studied for its ability to inhibit nicotinamide N-methyltransferase (NNMT)
GLP-1 receptor agonists provide significant reductions in HbA1c, weight loss, and cardiovascular benefits, making them highly preferred by clinicians for long-term management
Discover the ultimate solution for radiant, hydrated skin
Key Features Research Use Only (RUO) compound formulation Contains BPC-157 and TB-500 60 capsules per bottle Encapsulated format for ease of handling in laboratory settings Manufactured and packaged for research applications Product Specifications Compound Composition (per capsule): BPC-157 500 mcg TB-500 500 mcg Form: Capsules Bottle Size: 60 capsules Grade: Research Use Only (RUO) Intended Use This product is intended solely for laboratory research and investigational purposes
Initially, injections are given daily or every other day for a week, then weekly for 12 months, followed by monthly maintenance
